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ConCisE rEport
A novel variant in GLIS3 is associated 
with osteoarthritis
Elisabetta Casalone,1,2 ioanna tachmazidou,3 Eleni Zengini,4,5 
Konstantinos Hatzikotoulas,3 sophie Hackinger,3 Daniel suveges,3 Julia steinberg,3 
nigel William rayner,3,6,7 arcoGEn Consortium, Jeremy Mark Wilkinson,4 
Kalliope panoutsopoulou,3 Eleftheria Zeggini3
ABstrAct
Objectives osteoarthritis (oA) is a complex disease, 
but its genetic aetiology remains poorly characterised. 
to identify novel susceptibility loci for oA, we carried out 
a genome-wide association study (GWAs) in individuals 
from the largest UK-based oA collections to date.
Methods We carried out a discovery GWAs in 5414 oA 
individuals with knee and/or hip total joint replacement 
(tJr) and 9939 population-based controls. We followed-
up prioritised variants in oA subjects from the interim 
release of the UK Biobank resource (up to 12 658 cases 
and 50 898 controls) and our lead inding in operated 
oA subjects from the full release of UK Biobank (17 894 
cases and 89 470 controls). We investigated its functional 
implications in methylation, gene expression and 
proteomics data in primary chondrocytes from 12 pairs 
of intact and degraded cartilage samples from patients 
undergoing tJr.
results We detect a genome-wide signiicant 
association at rs10116772 with tJr (p=3.7×10−8; for 
allele A: or (95% Ci) 0.97 (0.96 to 0.98)), an intronic 
variant in GLIS3, which is expressed in cartilage. Variants 
in strong correlation with rs10116772 have been 
associated with elevated plasma glucose levels and 
diabetes.
conclusions We identify a novel susceptibility locus for 
oA that has been previously implicated in diabetes and 
glycaemic traits.
IntrOductIOn
Despite the considerable heritability and prev-
alence of osteoarthritis (OA), there has been 
limited success in unravelling its genetic aetiology. 
Genome-wide association studies (GWAS) have 
established 19 common variants associated with 
OA reaching or approaching genome-wide signifi-
cance.1 2 Six common variants have been associated 
with minimal joint space width with two of them 
also known to be associated with the dichotomous 
phenotypic definition of OA.3 The established, 
common knee and/or hip OA variants confer small 
effect sizes and account for just 11% of the disease 
heritability.1 Recently, two rare variations with large 
effect sizes in hip OA were identified by whole 
genome sequencing and imputation in a large-scale 
GWAS of Icelanders: one private to this population 
and a rare indel that is present in cosmopolitan 
populations.4 It is anticipated that larger sample 
sizes, harmonised phenotypes and interrogation 
of rare variation will enable the identification of 
further OA susceptibility loci.
Here we carried out a GWAS in 5414 OA cases 
and 9939 controls from the UK genotyped on the 
Illumina HumanCoreExome Beadchip. Our aim 
was to interrogate variants from the full minor 
allele frequency (MAF) spectrum including poten-
tially functional, rare coding variants with modest 
to large effects sizes in OA. We sought replication 
of our top signals in individuals with self-reported 
OA and in individuals with operation due to OA 
from the UK Biobank resource, in order to improve 
power by increasing sample size and by harmon-
ising phenotype definition, respectively.
MethOds
Full details of all methods are given in the online 
supplementary material 1, and the study design is 
summarised in online supplementary figure S1.
Briefly, we genotyped 6214 cases with hip and/
or knee OA from the arcOGEN study5 on three 
versions of the Illumina HumanCoreExome Bead-
chip: 12-v1.0, 12-v1.1 and 24-v1.0 (Ilumina, San 
Diego, California, USA). As controls, we used indi-
viduals from the UK Household Longitudinal Study6 
genotyped on the same chip (12-v1.0). Genotypes 
were called with GenCall, and standard GWAS 
quality control (QC) was conducted for each chip 
version separately at the sample and variant levels. 
We employed additional QC approaches to guard 
against chip effects (online  supplementary mate-
rial, figures S2 and S3). Following the data merge 
at the intersection of clean samples and variants, we 
included 5414 cases that were ascertained by total 
joint replacement (TJR) surgery, 9939 controls 
and 270 934 variants in downstream analyses. We 
performed three association analyses for knee and/
or hip TJR and stratified by joint. We prioritised 
variants with P<10ï for replication in OA case/
control sets from the interim release of UK Biobank.7 
Replication sets comprised either individuals with 
self-reported OA versus non-OA controls (12 658 
cases versus 50 898 controls) or individuals with hip 
and/or knee operation hospitalisation codes versus 
non-OA controls (up to 4015 cases versus 16 060 
controls) (online supplementary material, tables S1 
and S2). We followed up our lead finding in 17 894 
operated cases versus 89 470 non-OA controls from 
the full release of UK Biobank.8
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We performed fine mapping and bioinformatics queries in the 
region of association at the chr9 locus following imputation. 
Finally, we followed up the signal at rs10116772 using func-
tional genomics data (DNA methylation, gene expression and 
protein abundance) in primary chondrocytes from matched 
intact and degraded cartilage from 12 patients with OA under-
going total knee replacement.9 The data were analysed for signif-
icant differences between intact and degraded cartilage on the 
three -omics levels.9
results
We performed association analyses for three OA strata in the 
discovery study versus all 9939 controls (online supplemen-
tary table S3). Quantilequantile plots and Manhattan plots are 
shown in online supplementary figures S4 and S5. A total of 94 
variants (representing 68 independent signals) with P<10ï were 
prioritised for replication. Fifty-eight of these variants were not 
present in the previous arcOGEN GWAS5 due to limited overlap 
of single nucleotide polymorphism (SNP) content between plat-
forms (online supplementary material, tables S4 and S5). Seven-
ty-six of the prioritised variants were present in the interim UK 
Biobank dataset post-QC and underwent meta-analyses (online 
supplementary table S6).
We empirically evaluated replication power in three main 
OA phenotype classifications in the UK Biobank study: self-re-
ported OA (12 658 cases, 50 898 controls), hospital diagnosed 
OA (10 083 cases, 40 425 controls) and a subset of hospital-di-
agnosed OA subjects with operation codes (4015 cases, 16 060 
controls) (online supplementary material, tables S1 and S2). For 
the established OA loci, we find that the self-reported dataset is 
the only single study in Europeans that identifies the well-estab-
lished signal for OA at the growth/differentiation factor 3 gene 
(GDF5) with genome-wide significance. We also find that the 
much smaller, operation OA set is more powerful to detect vari-
ants associated with the more homogeneous, severe endpoint of 
TJR and/or with joint specificity (online supplementary mate-
rial and table S7). The evaluation of the accuracy of self-re-
ported OA status when compared with hospitalisation records 
shows modest sensitivity and high specificity, in line with results 
from other diseases studied in UK Biobank.10 These assessments 
underpinned our decision to include replication from the self-re-
ported and from the operation OA phenotype definitions for OA 
at any site and stratified by site.
rs10116772 (frequency of 0.40) reached genome-wide signif-
icance with P=3.2×10ï and OR (95% CI) 0.97 (0.96 to 0.98) 
following the meta-analysis of knee and/or hip OA TJR with the 
self-reported OA casecontrol dataset (online supplementary 
table S6). The direction of effect is concordant in the replica-
tion operation set versus controls, but the power decreases 
(meta-analysis P=1.4×10ï), commensurate with the signif-
icant decrease in sample size compared with the self-reported 
OA set (68% less samples) (online supplementary table S6). As 
a sensitivity analysis, we followed up this locus in the interme-
diate-sized dataset of hospital diagnosed OA versus controls and 
find concordant effect size (OR (95% CI) 0.97 (0.94 to 1)) and 
2.6-fold higher power (P=0.07) than in the operation subset 
(P=0.18). Motivated by this finding, we followed up the associ-
ation of rs10116772 in operated OA cases from the full release 
of the UK Biobank data, and we replicate it with genome-wide 
significance (P=3.7×10ï, OR (95% CI) 0.97 (0.96 to 0.98) for 
the same phenotype as the discovery study (table 1).
The association strength of rs10116772 was not attenuated 
following adjustment for height and body mass index (BMI) 
in our cohort (online supplementary material and online 
supplementary table S8). Furthermore, rs10116772 was not 
significantly associated with any of these traits in large-scale 
meta-analyses from Genetic Investigation of ANthropometric 
Traits (GIANT) and from the UK10K Consortia (online supple-
mentary material and table S9).
The regional association plot shows a narrow region of 
association in the GLIS Family Zinc Finger 3 (GLIS3) gene 
(figure 1). Imputation of this locus, fine mapping and bioinfor-
matics follow-up do not confidently predict the causal variant 
(online supplementary material, figure S6, tables S10 and S11). 
rs10116772 is in near-perfect LD (r2>0.99) with a genome-wide 
significant variant for fasting plasma glucose levels (rs4237150) 
and in moderate LD (r2>0.6) with variants that are associated 
with type 1 diabetes, type 2 diabetes and glycaemic traits (online 
supplementary table S12).
GLIS3 is expressed in cartilage at 12.5 mean fragments per 
kilobase of transcript per million mapped reads (FPKM), with SE 
1.1 and range 7.620.8, calculated based on 12 intact cartilage 
samples (figure 2). We do not detect differences in the expres-
sion, methylation and proteomics analyses between intact and 
degraded cartilage (online supplementary material).
dIscussIOn
We carried out a GWAS for OA TJR cases and controls geno-
typed on the CoreExome chip allowing us to interrogate variants 
from the full MAF spectrum. Our study is well powered (>80%) 
to detect common variants with small effect sizes at P=5×10ï, 
for example, an OR of 1.12 for a variant with a frequency of 
0.45%. For low-frequency (MAF 1%5%) and rare variants 
(MAF <1%), the study is well powered to detect variants with 
modest to large effects sizes (OR >1.2 and 1.45, respectively). 
Within the power constraints of our study, we do not detect any 
low frequency or rare variant associations of large effect with 
OA. This could be due to sample size and the incomplete probing 
of variation across the lower end of the allele frequency spec-
trum. For example, rs532464664, the rare indel identified by 
whole genome sequencing,4 is not directly typed in our GWAS 
or present in the Haplotype Reference Consortium imputation 
reference panel.
Our empirical evaluation of power in the different pheno-
type definitions of OA underpins our decision to employ 
two powerful and complementary replication approaches: 
replication from the self-reported OA dataset, empowered 
by its large sample size, and replication with the more homo-
geneous, severe endpoint of knee and/or hip operation. We 
identify a replicating genome-wide significant association at 
table 1 Summary statistics of rs10116772 in the discovery and replication studies
study stratum n (case/control) eA eAF P value Or (95% cI)
Discovery Knee and/or hip OA TJR versus controls 5410/9936 A 0.40 3.29×10–6 0.97 (0.96 to 0.98)
Replication Knee and/or hip OA operation versus non-OA controls 17 894/89 470 A 0.40 2.32×10–3 0.96 (0.94 to 0.99)
Meta-analysis 23 304/99 406 A 0.40 3.71×10–8 0.97 (0.96 to 0.98)
EA, effect allele; EAF, effect allele frequency; TJR, total joint replacement.
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rs10116772 with TJR, initially in the meta-analysis with the 
self-reported disease status of the UK Biobank interim release, 
which we follow up and establish in operated individuals 
only after a substantial sample size increase in the full UK 
Biobank data release. This demonstrates that the self-reported 
crude OA definition is a powerful tool for establishing genetic 
associations, which is in line with reports from other diseases 
studied in UK Biobank.1113
rs10116772 resides in an intron of GLIS3, which encodes 
a nuclear protein functioning as a repressor and activator of 
transcription.14 It is involved in the development of pancre-
atic beta cells, the thyroid, eye, liver and kidney, and muta-
tions in this gene cause a neonatal diabetes syndrome.15 16 
GLIS3 is regulated by the suppressor of fused homologue 
gene that encodes a negative regulator of hedgehog signal-
ling; modulating hedgehog signalling can attenuate the 
severity of OA.17 We find that GLIS3 is expressed in carti-
lage but we do notand are not well powered todetect 
differences in expression between intact and degraded artic-
ular cartilage to evaluate if the locus is associated with OA 
progression.
Within 4 kb and in strong correlation with the index variant 
(r2>0.6), there are a number of previously associated variants 
with type 1 diabetes, type 2 diabetes and related traits such as 
fasting plasma glucose. The alleles that lower fasting plasma 
glucose and increase the risk of type 1 and type 2 diabetes also 
increase the risk of OA (online supplementary table S12).
There is significant genetic correlation of OA with BMI and 
with type 2 diabetes genome wide, suggesting shared genetic 
aetiology.10 Mendelian randomisation analyses indicate that 
obesity, but not type 2 diabetes, has a causal effect on OA.10 
We have previously found an association at the FTO gene 
shared between obesity, type 2 diabetes and OA exerting its 
effect on OA and diabetes through increased BMI.18 19 This 
finding presents the first genetic link of OA and diabetes that 
is not exerted via increased risk of obesity, but the exact mech-
anism of OA susceptibility warrants further investigation.
Figure 1 Association of variants at GLIS3 with osteoarthritis. The x-axis shows the genomic interval, the left y-axis shows the statistical signiicance 
of association as negative log10 of P values. rs10116772 was used as the reference SNP and its P value in the discovery set, and postreplication is 
denoted by the purple circle and diamond, respectively. The linkage disequilibrium is presented as pairwise r2 between the reference SNP and the 
other SNPs in the region with colours according to different bins (0–0.2: dark blue; 0.2–0.4: light blue; 0.4–0.6: green; 0.6–0.8: orange; 0.8–1.0: red). 
The location of variants associated with other traits as reported in the NHGRI-EBI GWAS catalogue (P<10−5) is shown by the arrows. SNP, single 
nucleotide polymorphism.
Figure 2 Violin plot of the expression levels of GLIS3 based on 
intact cartilage from 12 individuals undergoing knee replacement 
surgery for primary osteoarthritis. The mean expression level of GLIS3 
(log10(MeanFPKM)) is shown by the red line. The inner black box shows 
the interquartile range (IQR, 25%–75% percentiles), the white dot is the 
median and the whiskers are the furthest point with distance not more 
than 1.5 times the IQR away from the median. FPKM, fragments per 
kilobase of transcript per million mapped reads.
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